Arcutis Biotherapeutics Inc (ARQT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.43B
Last updated: Nov 17, 2026 at 4:33 PM ET
Arcutis Biotherapeutics Inc (ARQT) Stock Chart
Arcutis Biotherapeutics (ARQT) has a latest price of $27.33 on Nov 17, 2026, 21.5% below its 52-week high of $34.80. Its price rose 9.3% over the past 12 months. The month-end price rose 51.4% over the 5 years through Oct 2026, a compound annual rate of 8.7%.
Price Chart
From Jan 2020 to Oct 2026, its highest month-end close was $34.17 in Feb 2021 and its lowest $1.84 in Nov 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ARQT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ARQT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 3.3%, and over 6 months it rose 40.2%. The month-end price rose 1,325.3% over the 3 years through Oct 2026, a compound annual rate of 142.5%.
| Period | Change |
|---|---|
| 1 month | -14.3% |
| 3 months | +3.3% |
| 6 months | +40.2% |
| 12 months | +9.3% |
| 12 months, with dividends | +9.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +1,325.3% | +142.5% |
| 5 years | +51.4% | +8.7% |
Price by Year
Its best calendar year was 2024, when the price rose 331.3%, and its weakest was 2023, when it fell 78.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $32.07 | +10.4% |
| 2025 | $29.04 | +108.5% |
| 2024 | $13.93 | +331.3% |
| 2023 | $3.23 | -78.2% |
| 2022 | $14.80 | -28.6% |
| 2021 | $20.74 | -26.3% |
Trading Range
The price is 1.2% below its 50-day average of $27.66 and 7.6% above its 200-day average of $25.40.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $27.33 | |
| 52-week high | $34.80 | -21.5% |
| 52-week low | $19.30 | +41.6% |
| 50-day average | $27.66 | -1.2% |
| 200-day average | $25.40 | +7.6% |
Price Risk
Over 3 years, its largest fall from a peak was 42.2%.
| Measure | Value |
|---|---|
| 1-year beta | 1.57 |
| Largest fall, 1 year | -37.5% |
| Largest fall, 3 years | -42.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ARQT
What is ARQT's 1-year price change?
Arcutis Biotherapeutics's price rose 9.3% over the past 12 months. With dividends included, the 12-month total return was 9.3%.
What is ARQT's 5-year price change?
Arcutis Biotherapeutics's month-end price rose 51.4% over the 5 years through Oct 2026, a compound annual rate of 8.7%. These figures leave out dividends.
What is ARQT's 52-week high and low?
Arcutis Biotherapeutics's 52-week high is $34.80 and its 52-week low is $19.30. Its latest price of $27.33 on Nov 17, 2026 is 21.5% below the high.
What is ARQT's beta?
Arcutis Biotherapeutics's 1-year beta against the S&P 500 is 1.57, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 37.5%.
Is the ARQT chart free?
Yes. Advanced Charting for ARQT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ARQT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors